1. The Chief Medical Officer shall, pursuant to the regulations adopted by the State Board of Health pursuant to NRS 439.4931, establish and maintain a system for the reporting of information on sickle cell disease and its variants.

2. The system established pursuant to subsection 1 must include a record of the cases of sickle cell disease and its variants which occur in this State along with such information concerning the cases as may be appropriate to form the basis for:

(a) Conducting comprehensive epidemiologic surveys of sickle cell disease and its variants in this State; and

(b) Evaluating the appropriateness of measures for the treatment of sickle cell disease and its variants.

3. Hospitals, medical laboratories and other facilities that provide screening, diagnostic or therapeutic services to patients with respect to sickle cell disease and its variants shall report the information prescribed by the State Board of Health pursuant to NRS 439.4931 to the system established pursuant to subsection 1.

4. Any provider of health care who diagnoses or provides treatment for sickle cell disease and its variants, except for cases directly referred to the provider or cases that have been previously admitted to a hospital, medical laboratory or other facility described in subsection 3, shall report the information prescribed by the State Board of Health pursuant to NRS 439.4931 to the system established pursuant to subsection 1.

5. As used in this section, “medical laboratory” has the meaning ascribed to it in NRS 652.060.

(Added to NRS by 2019, 2158)